Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-08-29

Clinical Trial Update: Topical Lidocaine: Predictors of Response in Peripheral Nerve Injury [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating predictors of response to topical lidocaine for neuropathic pain due to peripheral nerve injury. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topical lidocaine (lidocaine)

Snippet

Sponsor: Danish Pain Research Center | Conditions: Neuropathic Pain | Phase 4 | Status: COMPLETED